Sysmex to merge with wholly owned subsidiary Sysmex Medica

Sysmex Corporation announced that its board of directors approved an absorption-type merger with its wholly owned subsidiary, Sysmex Medica Co., Ltd. The merger, effective April 1, 2026, aims to optimize equipment production processes, improve efficiency, and enhance productivity within the Sysmex Group. This is a simplified and short-form merger, meaning no shareholder meetings will be held by either company for approval.

Sysmex Medica, which currently assembles diagnostic instrument units, will be dissolved, with Sysmex Corporation continuing as the surviving entity. There will be no issuance of new shares or other allotments related to the merger, as it involves a wholly owned subsidiary. Sysmex Corporation will retain its name, location, business description, and fiscal year-end post-merger.

The financial impact on Sysmex Corporation's consolidated results is expected to be minor, as this is a merger with a fully owned subsidiary. Sysmex Corporation reported total assets of JPY 665,268m and net sales of JPY 508,643m for the fiscal year ended March 31, 2025, while Sysmex Medica reported total assets of JPY 935m and net sales of JPY 2,482m for the same period.